RxDoctor Payments Data

Marshall Barker, DO

General Practice · Snow Hill, NCNPI 1083655005

Payments from drug & device makers

$702in general payments, 2019–2025

Across 39 payments — averaging $18.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$93
  • Redhill Biopharma Inc.$71
  • Pfizer$64
  • AbbVie$58
  • Astellas Pharma US Inc$57
  • Vanda Pharmaceuticals Inc.$51
  • plus $309 from 12 others

What the payments were for

  • Food & beverage$702100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$702 in reported general payments places this provider in the 75th percentile of 2,924 general practice providers in North Carolina.

See all general practice providers in North Carolina

Medicare billing

Part B allowed, 2024
$658
Medicare patients
23
Services billed
60

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol26$34,392
EliquisApixaban36$25,031
OzempicSemaglutide24$22,687
VraylarCariprazine Hcl12$17,684
JardianceEmpagliflozin27$16,175
XareltoRivaroxaban22$15,539
TrulicityDulaglutide14$14,090
SymbicortBudesonide/Formoterol Fumarate35$12,513
Repatha SureclickEvolocumab13$8,144
Spiriva HandihalerTiotropium Bromide15$7,732
LinzessLinaclotide13$6,587
JanuviaSitagliptin Phosphate12$6,459
MyrbetriqMirabegron11$5,436
LumiganBimatoprost14$3,533
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen63$2,580

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar, Linzess, Lumigan$58$27,80439 claims
PfizerEliquis$64$25,03136 claims
Boehringer IngelheimJardiance$16$16,17527 claims
Lilly USA, LLCTrulicity$12$14,09014 claims
MerckJanuvia$93$6,45912 claims
Astellas Pharma US IncMyrbetriq$57$5,43611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,924 general practice providers in North Carolina.

Other general practice in Snow Hill

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →